Diagnostic and Prognostic Models

All Items

• 

  Role of telomere maintenance genes as a predictive biomarker for colorectal cancer immunotherapy response and prognosis

  Zhikai Wang, Chunyan Zhao, Yifen Huang, Chong Li

  2696–2711
• 

  Risk and prognosis of second cutaneous melanoma after radiotherapy for breast cancer: A population-based analysis

  Tianxin Luo, Yani Zhang, Tianliang Chen, Yanxia Cai, Zheng Yang

  959-967
• 

  Refining PD-1/PD-L1 assessment for biomarker-guided immunotherapy: A review

  Marek Zdrenka, Adam Kowalewski, Navid Ahmadi, Rizwan Ullah Sadiqi, Łukasz Chmura, Jędrzej Borowczak, Mateusz Maniewski, Łukasz Szylberg

  14–29
• 

  Prognostic value of Naples Prognostic Score in locally advanced cervical cancer patients undergoing concurrent chemoradiotherapy

  Xiaojun Zhang, Mengxuan Gu, Jiahao Zhu, Ruike Gu, Bo Yang, Shengjun Ji, Yutian Zhao, Ke Gu

  986–999
• 

  Prognostic value of immunotherapy in advanced NSCLC based on baseline and dynamic changes in HALP

  Hui Su, Chao Yu, Guiming Sun, Baozhong Wang, Yingjie Gao, Xiaolan Liu, Qingcui Song, Xuezhen Ma

  29–41
• 

  Prognostic significance and immunological role of HPRT1 in human cancers

  Yiwen Lu, Ruixue Chen, Han Zhang, Xu Sun, Xiangjun Li, Mengyuan Yang, Xudong Zhang

  262–291
• 

  Prognostic impact of pan-immune inflammation value in small-cell lung cancer treated with chemoradiotherapy and prophylactic cranial irradiation

  Aybala Nur Ucgul, Huseyin Hazir, Huseyin Bora

  2658–2665
• 

  Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

  Sabin Goktas Aydin, Engin Eren Kavak, Atakan Topcu, Ayberk Bayramgil, Fahri Akgul, Seda Kahraman, Musa Baris Aykan, Yunus Emre Altıntas, Kaan Helvaci, Yuksel Urun, Ahmet Bilici, Mesut Seker, Mehmet Ali Nahit Sendur, Omer Fatih Olmez, Ozgur Acikgoz, Irfan Cicin

  1089–1095
• 

  Prognostic evaluation in gallbladder carcinoma: Introducing a composite risk model integrating nutritional and immune markers

  Si-qi Yang, Rui-qi Zou, Yu-shi Dai, Hai-jie Hu, Fu-yu Li

  425–435
• 

  Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

  Marija Kraljević, Inga Marijanović, Maja Barbarić, Emir Sokolović, Merima Bukva, Timur Cerić, Teo Buhovac

  161-169
• 

  Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome

  Bedrettin Orhan, Hülya Öztürk Nazlıoğlu, Oğuzhan Dik, Büşra Gürbüz, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar, Cumali Yalçın, Sinem Çubukçu, Tuba Güllü Koca, Fazıl Çağrı Hunutlu, Şeyma Yavuz, Rıdvan Ali, Fahir Özkalemkaş

  1175–1183
• 

  Predictive and prognostic value of preoperative pan-immune-inflammation value in patients with locally advanced rectal cancer

  Peipei Shen, Yu Xu, Jiahao Zhu, Danqi Qian, Bo Yang, Yong Mao, Shengjun Ji, Ke Gu, Yutian Zhao

  1000–1008
• 

  Prediction of post-insertion infections related to totally implantable subcutaneous venous access ports in tumor patients using a nomogram

  Sen Wang, Heng Zong, Lei Tang, Yuandong Wei

  1601–1609
• 

  Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world study

  Jifeng Feng, Liang Wang, Xun Yang, Qixun Chen, Xiangdong Cheng

  153-160
• 

  Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index

  Nulifer Kilic Durankus, Efsun Somay, Sibel Bascil, Sukran Senyurek, Duriye Ozturk, Ugur Selek, Erkan Topkan

  240–248
• 

  PD-L1 testing by immunohistochemistry in immuno-oncology

  Semir Vranic, Zoran Gatalica

  15-25
• 

  Parathyroid hormone-related protein as a potential prostate cancer biomarker: Promoting prostate cancer progression through upregulation of c-Met expression

  Yan Zhao, Zhen-Yu Fu, Han-Yong Feng, Yu-Hao Peng, Zhi-Xiang Yin, Jing-Yi Cao, Chang-Song Pei

  374–386
• 

  Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis

  Xuemin Zeng, Dapeng Ren, Ran Liu, Qiang Zhang, Xiao Yan, Xiao Yuan

  952-958
• 

  OncoImmune machine-learning model predicts immune response and prognosis in leiomyosarcoma

  Jingrong Deng, Changfa Shu, Dong Wang, Richard Nimbona, Xingping Zhao, Dabao Xu

  2308–2323
• 

  Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study

  Zhenchi Li, Zhibin Xu, Jiangping Wang, Mei Wang

  633–646